Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2001 | 12-2000 | 12-1999 | |
Sales | 18,060 | 7,683 | 0 |
Gross Profit | 18,060 | 7,683 | N/A |
Operating Expenses | 33,775 | 19,102 | 10,529 |
Operating Income | -15,715 | -11,419 | -10,529 |
Interest Expense | 112 | 221 | 166 |
Other Income | 8,945 | 5,277 | 456 |
Pre-tax Income | -6,883 | -6,362 | -10,238 |
Net Income Continuous | -6,883 | -6,362 | -10,238 |
Net Income | $-6,883 | $-6,362 | $-10,238 |
EPS Basic Total Ops | -2.80 | -28.40 | -100.50 |
EPS Basic Continuous Ops | -2.75 | -6.27 | -100.57 |
EPS Diluted Total Ops | -2.80 | -28.40 | -100.50 |
EPS Diluted Continuous Ops | -2.75 | -6.27 | -100.57 |
EBITDA(a) | $-8,513 | $-6,288 | $-9,751 |